Cargando…
Stimulated Whole Blood Cytokine Release as a Biomarker of Immunosuppression in the Critically Ill: The Need for a Standardized Methodology
OBJECTIVE: Reduced ex vivo lipopolysaccharide (LPS) stimulated whole blood pro-inflammatory cytokine release is a hallmark of immunosuppression in the critically ill and predicts adverse clinical outcomes. No standard technique for performing the assay currently exists. The impact of methodological...
Autores principales: | Segre, Elisabetta, Fullerton, James N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836558/ https://www.ncbi.nlm.nih.gov/pubmed/27089173 http://dx.doi.org/10.1097/SHK.0000000000000557 |
Ejemplares similares
-
Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
por: Ponce, Daniela, et al.
Publicado: (2022) -
Characteristics of chronically critically ill patients: comparing two definitions
por: Boniatti, Márcio Manozzo, et al.
Publicado: (2011) -
Ribavirin Treatment for Critically Ill COVID-19 Patients: An Observational Study
por: Xu, Yonghao, et al.
Publicado: (2021) -
The case for early use of rapid whole-genome sequencing in management of critically ill infants: late diagnosis of Coffin–Siris syndrome in an infant with left congenital diaphragmatic hernia, congenital heart disease, and recurrent infections
por: Sweeney, Nathaly M., et al.
Publicado: (2018) -
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
por: Leisman, Daniel E, et al.
Publicado: (2020)